Navigation Links
Americans Living Longer, Healthier Lives Due to Medical Innovation and New Therapies

WASHINGTON, Feb. 23 /PRNewswire-USNewswire/ -- An article in the Journal Miner recently highlighted the fact that many people are living longer, healthier and more productive lives thanks to medical innovation and research.

"A strong, innovative and creative pharmaceutical research and biotechnology sector based in the United States is a real boon to American patients," said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA).

For example, according to a study in Health Affairs, cancer patients live three years longer on average than thirty years ago; 83 percent of that gain is the result of new treatments. In addition, there was a nearly 50 percent decline in heart failure- and attack-related deaths between 1999 and 2005. The rate of AIDS deaths has fallen by more than 70 percent since highly active anti-retroviral therapies were developed, blood pressure medicines prevented 86,000 premature deaths from cardiovascular disease and avoided 833,000 hospitalizations for heart attack and stroke in just one year.

America's pharmaceutical research and biotechnology companies are leading the charge. "American patients often get access to new and better medicines well ahead of patients around the world, and this homegrown innovation not only saves lives, it helps the American economy by employing millions of Americans and pumping billions of dollars into our local and national economies," Tauzin said.

The Congressional Budget Office specifically identified America's biopharmaceutical sector as "one of the most research-intensive industries" in America. Tauzin said, "It's important to keep in mind that developing new therapies can be risky, expensive and time consuming. Creating a new medicine, on average, takes between 10 and 15 years and can cost $1.3 billion. But it's an investment biopharmaceutical research companies make because nothing is as important as the search for new cures and treatments that help patients live longer, healthier lives."

SOURCE Pharmaceutical Research and Manufacturers of America

Back to top



SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
3. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
5. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
6. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
7. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
8. Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
9. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
10. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
11. New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 NHS Supply ... 20 TrueBeam™ machines from Varian Medical Systems (NYSE: ... program to replace older machines and institute modern ... UK,s public hospitals. The order, placed in September, ... licenses for Varian,s RapidArc® and Eclipse™ software systems.    ...
(Date:11/30/2015)... , Nov. 30, 2015  Hanger, Inc. (NYSE: ... restatement of the terms of its previously announced consent ... to its $200,000,000 aggregate principal amount 7⅛% Senior Notes ... (i) the consent fees payable pursuant to the Consent ... Notes and (iii) the expiration date of the Consent ...
(Date:11/30/2015)... , Nov. 30, 2015  Precision Image ... services, is pleased to announce a dramatic expansion ... imaging services. Building on its ISO-9001:2008 certification for ... implemented comprehensive Core Lab protocols and procedures. This ... of research activities.  Their Core Lab services include ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... Center is one of a select few plastic surgeons in the New York ... removal. , SculpSure™ is the world’s first heat-induced laser treatment for fat loss ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... TransPack Volume ... X . Choose from scrolling web-styled transitions to wipes with blur & drop ... direction and more. Seamlessly transition from one clip to the next with TransPack's ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... their strategic partnership at the Radiological Society of North America (RSNA) 2015 ... global providers of cutting-edge dictation and speech-enabled documentation software, announced their partnership ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... In 2016, expected coding changes are likely to include new codes for spine ... not easy to understand the effects of code changes in musculoskeletal, radiology and ...
(Date:11/30/2015)... ... 30, 2015 , ... CTI Group (Holdings) Inc. (OTC:CTIG), a ... communication analytics, announced today that their Proteus® VoIP QMS solution now supports Skype ... Proteus® VoIP QMS (Quality Management System) does this by collecting the ...
Breaking Medicine News(10 mins):